Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
European Urology Oncology|July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily IrradiationDouglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
International Journal of Molecular Sciences|March 10, 2022
Non-Invasive Profiling of Advanced Prostate Cancer via Multi-Parametric Liquid Biopsy and Radiomic AnalysisGareth Morrison, Jonathan Buckley, Dejerianne Ostrow, et al.
European Journal of Radiology Open|September 12, 2022
Feasibility of using CT radiomic signatures for predicting CD8-T cell infiltration and PD-L1 expression in renal cell carcinomaBino Varghese, Steven Cen, Haris Zahoor, et al.
Plos One|August 23, 2014
The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladderXiuqing Li, Wesley W Choi, Rui Yan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate CancerW Robert Lee, James J Dignam, Mahul B Amin, et al.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415Maria Thor, Joseph O Deasy, Rebecca Paulus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, NeratinibGary A Ulaner, Cristina Saura, Sarina A Piha-Paul, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate CancerStuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Cancer Chemotherapy and Pharmacology|November 28, 2025
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancerStuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Pageof 12